Docosahexaenoic Acid and Preterm Birth

Area of Science:

• Obstetrics and Gynecology
• Nutritional Science
• Perinatal Medicine

Background:

• Preterm birth is a leading cause of perinatal complications and infant mortality.
• Many preterm births have unknown causes, lacking effective prevention strategies.
• High fish consumption is linked to longer gestation periods.

Purpose of the Study:

• To review evidence on prenatal omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) supplementation.
• To discuss the relationship between n-3 LCPUFA intake and preterm birth incidence.
• To evaluate n-3 LCPUFA as a potential prophylactic intervention.

Main Methods:

• Systematic review of randomized controlled trials.
• Analysis of epidemiological data on fish consumption and gestation length.
• Synthesis of current evidence on n-3 LCPUFA supplementation during pregnancy.

Main Results:

• Randomized controlled trials suggest n-3 LCPUFA supplementation may delay birth timing.
• Evidence indicates potential prophylactic value in certain populations.
• Further research is ongoing to confirm efficacy and optimal use.

Conclusions:

• Prenatal n-3 LCPUFA supplementation shows promise in potentially reducing preterm birth.
• Dietary n-3 LCPUFA may be a valuable intervention for some pregnant women.
• Understanding the role of n-3 LCPUFA in pregnancy is crucial for improving perinatal outcomes.